Examkin

Question

Difficulty: MediumPediatric Endocrine Disorders

A 6-year-old girl is brought to the pediatric endocrinology clinic by her parents due to breast development and rapid growth over the past 6 months. Physical examination reveals Tanner stage 3 breast development and Tanner stage 2 pubic hair. Her height has recently crossed from the 50th to the 95th percentile for age. Assuming her evaluation ultimately leads to a diagnosis of idiopathic central precocious puberty requiring pharmacotherapy, arrange the following clinical steps in the correct chronological order from initial diagnostic evaluation to final management.

  1. 1Obtain a radiograph of the left hand and wrist to assess bone age
  2. 2Measure basal serum luteinizing hormone (LH) and follicle-stimulating hormone (FSH) levels
  3. 3Perform a gonadotropin-releasing hormone (GnRH) stimulation test
  4. 4Obtain magnetic resonance imaging (MRI) of the brain
  5. 5Initiate therapy with a long-acting GnRH agonist

Answer

The correct chronological sequence is: 1) Assess bone age, 2) Measure basal LH/FSH, 3) Perform GnRH stimulation test, 4) Obtain brain MRI, 5) Initiate GnRH agonist therapy.
The evaluation of precocious puberty follows a strict, step-wise algorithm designed to minimize unnecessary or invasive testing. The initial step is always assessing skeletal maturation (bone age) to differentiate true precocious puberty from isolated premature thelarche or adrenarche. Once advanced bone age confirms true precocious puberty, the source of sex steroids must be localized. This is done by measuring basal gonadotropins (LH/FSH). Because basal LH can be prepubertal in the early stages of central precocious puberty, a GnRH stimulation test is often the necessary subsequent step to biochemically confirm central activation. Once central precocious puberty is proven, a brain MRI is mandatory in girls younger than 8 years to rule out an underlying central nervous system lesion (such as a hypothalamic hamartoma). If the MRI is negative, the diagnosis is idiopathic central precocious puberty, and the final step is initiating treatment with a long-acting GnRH agonist to arrest pubertal progression and preserve adult height potential.

Step-by-Step Solution

1
Differentiate true precocious puberty from benign premature thelarche.
Obtain a bone age radiograph.
Rapid linear growth and breast development require confirmation of skeletal advancement before invasive hormone testing.
2
Determine if the precocious puberty is centrally or peripherally driven.
Measure basal LH and FSH.
High basal LH indicates a central etiology, while low LH indicates peripheral etiology or early central puberty.
3
Confirm central activation if basal LH is equivocal or prepubertal.
Perform a GnRH stimulation test.
A pubertal LH response to GnRH stimulation definitively diagnoses central precocious puberty.
4
Rule out intracranial pathology causing the central activation.
Obtain a brain MRI.
Girls under 8 years with confirmed central precocious puberty have a significant risk of CNS lesions (e.g., hypothalamic hamartoma, tumors).
5
Manage the idiopathic central precocious puberty.
Initiate long-acting GnRH agonist therapy.
Continuous administration of a GnRH agonist downregulates pituitary GnRH receptors, suppressing gonadotropin release and halting early puberty.

Key Concept

The diagnostic algorithm for central precocious puberty begins with a bone age assessment, followed by basal and stimulated gonadotropin testing, neuroimaging to rule out CNS tumors, and finally, medical suppression with a GnRH agonist.
Estimated Time:1m 30s
Rate this question

Topics

Pediatric Endocrine Disorders

More questions from this topic